DKK1 and plasma cell myeloma: Another potential therapeutic target for myeloma bone disease in the canonical Wnt/ß-catenin pathway is Dickkopf-related protein 1 (DKK-1), an inhibitor of the pathway secreted by myeloma cells in addition to osteoblasts and bone marrow stromal cells (BMSC).